• Intellia Therapeutics (NASDAQ:NTLA) Receives Sell Rating from The Goldman Sachs Group

    Source: Buzz FX / 01 Mar 2025 07:32:14   America/Chicago


    Intellia Therapeutics (NASDAQ:NTLA) Receives Sell Rating from The Goldman Sachs Group Written by MarketBeat March 1, 2025 Share Link copied to clipboard. Intellia Therapeutics ( NASDAQ:NTLA - Get Free Report ) 's stock had its "sell" rating
    Read more...
Share on,